Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ITF2357 (Givinostat) for Active Crohn's Disease
NCT00792740Phase 2Terminated
- Sponsor
- Italfarmaco
- Start
- Oct 2007
- Primary completion
- Dec 2008
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of givinostat in Crohn's disease, sponsored by Italfarmaco. Started Oct 2007; status: terminated.
02
Drugs
givinostat
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT00792740.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00792740.